159 related articles for article (PubMed ID: 35672625)
1. Fertility Preservation in Young Women with Breast Cancer: Impact on Treatment and Outcomes.
Crown A; Muhsen S; Sevilimedu V; Kelvin J; Goldfarb SB; Gemignani ML
Ann Surg Oncol; 2022 Sep; 29(9):5786-5796. PubMed ID: 35672625
[TBL] [Abstract][Full Text] [Related]
2. Does Use of Neoadjuvant Chemotherapy Affect the Decision to Pursue Fertility Preservation Options in Young Women with Breast Cancer?
Crown A; Muhsen S; Zabor EC; Sevilimedu V; Kelvin J; Goldfarb SB; Gemignani ML
Ann Surg Oncol; 2020 Nov; 27(12):4740-4749. PubMed ID: 32767225
[TBL] [Abstract][Full Text] [Related]
3. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer.
Letourneau JM; Sinha N; Wald K; Harris E; Quinn M; Imbar T; Mok-Lin E; Chien AJ; Rosen M
Hum Reprod; 2017 Oct; 32(10):2123-2129. PubMed ID: 28938748
[TBL] [Abstract][Full Text] [Related]
4. Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation.
Letourneau JM; Wald K; Sinha N; Juarez-Hernandez F; Harris E; Cedars MI; McCulloch CE; Dolezal M; Chien AJ; Rosen MP
Cancer; 2020 Feb; 126(3):487-495. PubMed ID: 31639215
[TBL] [Abstract][Full Text] [Related]
5. Risk of recurrence and pregnancy outcomes in young women with breast cancer who do and do not undergo fertility preservation.
Wang Y; Tesch ME; Lim C; Xu YH; Lee S; Perdizet K; Yokom D; Warner E; Roberts J; Lohrisch CA
Breast Cancer Res Treat; 2022 Sep; 195(2):201-208. PubMed ID: 35908122
[TBL] [Abstract][Full Text] [Related]
6. Survey of young women with breast cancer to identify rates of fertility preservation (FP) discussion and barriers to FP care.
Sauerbrun-Cutler MT; Pandya S; Recabo O; Raker C; Clark MA; Robison K
J Assist Reprod Genet; 2023 Aug; 40(8):2003-2011. PubMed ID: 37329421
[TBL] [Abstract][Full Text] [Related]
7. The impact of fertility preservation on the timing of breast cancer treatment, recurrence, and survival.
Greer AC; Lanes A; Poorvu PD; Kennedy P; Thomas AM; Partridge AH; Ginsburg ES
Cancer; 2021 Oct; 127(20):3872-3880. PubMed ID: 34161610
[TBL] [Abstract][Full Text] [Related]
8. Reproductive Outcomes After Breast Cancer in Women With vs Without Fertility Preservation.
Marklund A; Lundberg FE; Eloranta S; Hedayati E; Pettersson K; Rodriguez-Wallberg KA
JAMA Oncol; 2021 Jan; 7(1):86-91. PubMed ID: 33211089
[TBL] [Abstract][Full Text] [Related]
9. Experience of young women diagnosed with breast cancer who undergo fertility preservation consultation.
Hill KA; Nadler T; Mandel R; Burlein-Hall S; Librach C; Glass K; Warner E
Clin Breast Cancer; 2012 Apr; 12(2):127-32. PubMed ID: 22444719
[TBL] [Abstract][Full Text] [Related]
10. Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservation.
Moravek MB; Confino R; Lawson AK; Smith KN; Kazer RR; Klock SC; Gradishar WJ; Jeruss JS; Pavone ME
Breast Cancer Res Treat; 2021 Apr; 186(2):429-437. PubMed ID: 33392838
[TBL] [Abstract][Full Text] [Related]
11. Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience.
Vriens IJH; Ter Welle-Butalid EM; de Boer M; de Die-Smulders CEM; Derhaag JG; Geurts SME; van Hellemond IEG; Luiten EJT; Dercksen MW; Lemaire BMD; van Haaren ERM; Vriens BEPJ; van de Wouw AJ; van Riel AMGH; Janssen-Engelen SLE; van de Poel MHW; Schepers-van der Sterren EEM; van Golde RJT; Tjan-Heijnen VCG
Breast Cancer Res Treat; 2020 May; 181(1):77-86. PubMed ID: 32236826
[TBL] [Abstract][Full Text] [Related]
12. Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.
Chien AJ; Chambers J; Mcauley F; Kaplan T; Letourneau J; Hwang J; Kim MO; Melisko ME; Rugo HS; Esserman LJ; Rosen MP
Breast Cancer Res Treat; 2017 Aug; 165(1):151-159. PubMed ID: 28503722
[TBL] [Abstract][Full Text] [Related]
13. What factors hinder the decision-making process for women with cancer and contemplating fertility preservation treatment?
Jones G; Hughes J; Mahmoodi N; Smith E; Skull J; Ledger W
Hum Reprod Update; 2017 Jul; 23(4):433-457. PubMed ID: 28510760
[TBL] [Abstract][Full Text] [Related]
14. Elective and Onco-fertility preservation: factors related to IVF outcomes.
Cobo A; García-Velasco J; Domingo J; Pellicer A; Remohí J
Hum Reprod; 2018 Dec; 33(12):2222-2231. PubMed ID: 30383235
[TBL] [Abstract][Full Text] [Related]
15. Fertility Preservation for the Young Breast Cancer Patient.
Goldfarb SB; Kamer SA; Oppong BA; Eaton A; Patil S; Junqueira MJ; Olcese C; Kelvin JF; Gemignani ML
Ann Surg Oncol; 2016 May; 23(5):1530-6. PubMed ID: 26790670
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Safety of Letrozole and Gonadotropin Stimulation for Fertility Preservation in Women With Breast Cancer.
Kim J; Turan V; Oktay K
J Clin Endocrinol Metab; 2016 Apr; 101(4):1364-71. PubMed ID: 26751194
[TBL] [Abstract][Full Text] [Related]
17. Does a dedicated program for young breast cancer patients affect the likelihood of fertility preservation discussion and referral?
Srikanthan A; Amir E; Warner E
Breast; 2016 Jun; 27():22-6. PubMed ID: 27212696
[TBL] [Abstract][Full Text] [Related]
18. Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer Diagnosis.
Marklund A; Lekberg T; Hedayati E; Liljegren A; Bergh J; Lundberg FE; Rodriguez-Wallberg KA
JAMA Oncol; 2022 Oct; 8(10):1438-1446. PubMed ID: 36006625
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of controlled ovarian stimulation using GnRH antagonist protocols for emergency fertility preservation in young women with breast cancer-a prospective nationwide Swedish multicenter study.
Marklund A; Eloranta S; Wikander I; Kitlinski ML; Lood M; Nedstrand E; Thurin-Kjellberg A; Zhang P; Bergh J; Rodriguez-Wallberg KA
Hum Reprod; 2020 Apr; 35(4):929-938. PubMed ID: 32313940
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Fertility Preservation Counseling and Treatments for Female Oncology Patients in an Urban Pediatric Canadian Center.
Grégoire-Briard F; Mitsakakis N; Hayawi L; Dumont T
J Adolesc Young Adult Oncol; 2022 Oct; 11(5):518-524. PubMed ID: 34936499
[No Abstract] [Full Text] [Related]
[Next] [New Search]
